FDA
approval
· 2017-08-09
FDA Approved: NUVARING — Supplemental Application (Advanz Pharma (US) Corp.)
Summary
FDA approved a supplemental application for NuvaRing (etonogestrel and ethinyl estradiol) submitted by Advanz Pharma (US) Corp.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NUVARING (ETONOGESTREL AND ETHINYL ESTRADIOL)